A new nicotine inhaler to be sold by a unit of British American Tobacco has been licensed in Britain as a medicinal product, marking the arrival of a novel alternative in the fast-growing market for electronic cigarettes.

A RANGE of nicotine products aimed at people seeking a “safer” alternative to cigarettes are to be developed by an international tobacco group.